Cargando…
Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma
BACKGROUND: Drug-induced immune hemolytic anemia (DIIHA) is a rare but potentially life-threatening drug-related complication. There are no previous reports of pemetrexed plus cisplatin as first-line chemotherapy for non-small cell lung cancer, resulting in DIIHA. CASE PRESENTATION: In this report,...
Autores principales: | Lu, Hongkai, Wang, Na, Wang, Peng, Zhang, Haolin, Zhao, Ru, Liu, Hongju, He, Xirong, Liu, Zeya, Chang, Yue, Cao, Yongtong, Wang, Shiyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452692/ https://www.ncbi.nlm.nih.gov/pubmed/36091696 http://dx.doi.org/10.3389/fmed.2022.917485 |
Ejemplares similares
-
Cold agglutinin-induced hemolytic anemia as the primary presentation in SLE - A case report
por: Mohanty, Bijaya, et al.
Publicado: (2019) -
Efficacy of cisplatin/pemetrexed with bevacizumab to treat advanced lung adenocarcinoma with different drive genes: case report and literature review
por: Wang, Haiyong, et al.
Publicado: (2016) -
A Case of Lung Adenocarcinoma with Marked Improvement of Pulmonary Lymphangitic Carcinomatosis by Adding Bevacizumab to Cisplatin and Pemetrexed
por: Natsume, Maika, et al.
Publicado: (2017) -
Prognostic value of serum leptin in advanced lung adenocarcinoma patients with cisplatin/pemetrexed chemotherapy
por: MOU, WENJUN, et al.
Publicado: (2014) -
Choroid metastases revealing primary clear cell adenocarcinoma of the lung effectively treated with cisplatin and pemetrexed: a case report
por: Chang, Yueh-Shih, et al.
Publicado: (2013)